SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-16-015428
Filing Date
2016-03-16
Accepted
2016-03-16 16:26:20
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1536471
2 GRAPHIC g128073g00b99.jpg GRAPHIC 116125
3 GRAPHIC g128073g17m78.jpg GRAPHIC 81530
4 GRAPHIC g128073g17t17.jpg GRAPHIC 60334
5 GRAPHIC g128073g21c22.jpg GRAPHIC 52329
6 GRAPHIC g128073g22x07.jpg GRAPHIC 52260
7 GRAPHIC g128073g42g81.jpg GRAPHIC 88567
8 GRAPHIC g128073g49o56.jpg GRAPHIC 31604
9 GRAPHIC g128073g75c84.jpg GRAPHIC 78697
10 GRAPHIC g128073g80g86.jpg GRAPHIC 72125
11 GRAPHIC g128073g81a51.jpg GRAPHIC 142430
12 GRAPHIC g128073g88m25.jpg GRAPHIC 80852
13 GRAPHIC g128073g90u64.jpg GRAPHIC 100375
14 GRAPHIC g128073g93s45.jpg GRAPHIC 51663
15 GRAPHIC g128073g94w44.jpg GRAPHIC 162183
16 GRAPHIC g1280731.jpg GRAPHIC 2645
17 filename17.htm COVER 31109
  Complete submission text file 0000950123-16-015428.txt   3186125
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01260 | Film No.: 161510001
SIC: 2834 Pharmaceutical Preparations